Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease: A Nationwide Study of Veterans
Arthritis Care & Research · 2023-02 · 75 (2) · 277-282
DOI: 10.1002/acr.24783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 11.10.2022. Verfasst von Maaman Bashir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Wisconsin, Milwaukee. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Cardiovascular Diseases, Chondrocalcinosis, Veterans. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Objective
Calcium pyrophosphate deposition (CPPD) disease represents a common crystalline arthritis with a range of manifestations. Our goal was to investigate risks for cardiovascular events in patients with CPPD.
Methods
We performed a retrospective matched cohort analysis in the Veterans Health Administration Corporate Data Warehouse, 2010–2014. CPPD was defined by ≥1 International Classification of Diseases, Ninth Revision codes for chondrocalcinosis or calcium metabolism disorder. CPPD patients were age‐ and sex‐matched to approximately 4 patients without codes for CPPD; we excluded patients with a cardiovascular event during the 365 days prior to the index date. Demographic information, traditional cardiovascular risk factors, medications, and health care utilization were assessed at baseline. The primary outcome was a major adverse cardiovascular event (MACE: myocardial infarction, acute coronary syndrome, coronary revascularization, stroke, or death). Secondary outcomes included individual components of MACE. Cox proportional hazards models estimated fully adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs).
Results
We identified 23,124 CPPD patients matched to 86,629 non‐CPPD patients with >250,000 person‐years of follow‐up. The study population was 96% male, mean age was 78 years, and 75% were White. The frequency of traditional cardiovascular risk factors was similar between the 2 cohorts. CPPD was not significantly associated with risk for MACE (HR 0.98 [95% CI 0.94–1.02]) in fully adjusted models, though risks of myocardial infarction, acute coronary syndrome, and stroke were significantly higher in the CPPD cohort compared to the non‐CPPD cohort.
Conclusion
CPPD did not confer an increased risk for MACE, a composite end point including all‐cause mortality. Our results propose CPPD as a novel risk factor for MACE components, including myocardial infarction, acute coronary syndrome, and stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Medical College of Wisconsin, Milwaukee.
- Zablocki VA Medical Center, Milwaukee, Wisconsin.
- Brigham and Women's Hospital, Boston, Massachusetts.
- Medical College of Wisconsin and Zablocki VA Medical Center, Milwaukee.
ORCID-Profile: Daniel H Solomon, Sara K Tedeschi
Förderung
- BLRD VA
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- U.S. Department of Veterans Affairs
Zitieren
APA
Bashir, M., Sherman, K. A., Solomon, D. H., Rosenthal, A., & Tedeschi, S. K. (2023). Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease: A Nationwide Study of Veterans. Arthritis Care & Research, 75(2), 277-282. https://doi.org/10.1002/acr.24783
Vancouver
Bashir M, Sherman KA, Solomon DH, Rosenthal A, Tedeschi SK. Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease: A Nationwide Study of Veterans. Arthritis Care & Research. 2023;75(2):277-282. doi:10.1002/acr.24783
BibTeX
@article{Bashir2023,
author = {Bashir, Maaman and Sherman, Katherine A and Solomon, Daniel H and Rosenthal, Ann and Tedeschi, Sara K},
title = {Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease: A Nationwide Study of Veterans},
journal = {Arthritis Care & Research},
year = {2023},
volume = {75},
number = {2},
pages = {277--282},
doi = {10.1002/acr.24783}
}
EUVIMED